Alcohol use disorder relapse factors: A systematic review.
Sliedrecht W, de Waart R, Witkiewitz K, Roozen HG.
Psychiatry Res. 2019 Aug;278:97-115. doi: 10.1016/j.psychres.2019.05.038. Epub 2019 May 25.
Harmonizing Definitions for Progression Independent of Relapse Activity in Multiple Sclerosis: A Systematic Review.
Müller J, Cagol A, Lorscheider J, Tsagkas C, Benkert P, Yaldizli Ö, Kuhle J, Derfuss T, Sormani MP, Thompson A, Granziera C, Kappos L.
JAMA Neurol. 2023 Nov 1;80(11):1232-1245. doi: 10.1001/jamaneurol.2023.3331.
How patients with multiple sclerosis acquire disability.
Lublin FD, Häring DA, Ganjgahi H, Ocampo A, Hatami F, Čuklina J, Aarden P, Dahlke F, Arnold DL, Wiendl H, Chitnis T, Nichols TE, Kieseier BC, Bermel RA.
Brain. 2022 Sep 14;145(9):3147-3161. doi: 10.1093/brain/awac016.
Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
Bergamaschi L, Chiaravalli S, Livellara V, Sironi G, Puma N, Nigro O, Gattuso G, Luksch R, Terenziani M, Spreafico F, Meazza C, Podda M, Biassoni V, Schiavello E, Hovsepyan S, Morosi C, Vennarini S, Massimino M, Casanova M, Ferrari A.
Pediatr Blood Cancer. 2023 Jan;70(1):e30050. doi: 10.1002/pbc.30050. Epub 2022 Oct 10.
Relapse after allogeneic stem cell transplantation.
Barrett AJ, Battiwalla M.
Expert Rev Hematol. 2010 Aug;3(4):429-41. doi: 10.1586/ehm.10.32.
Acute Multiple Sclerosis Relapse.
Berkovich RR.
Continuum (Minneap Minn). 2016 Jun;22(3):799-814. doi: 10.1212/CON.0000000000000330.
Relapsed Acute Lymphoblastic Leukemia.
Sidhu J, Gogoi MP, Krishnan S, Saha V.
Indian J Pediatr. 2024 Feb;91(2):158-167. doi: 10.1007/s12098-023-04635-4. Epub 2023 Jun 21.
Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.
Kalincik T.
Neuroepidemiology. 2015;44(4):199-214. doi: 10.1159/000382130. Epub 2015 May 20.
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset.
Koch MW, Moral E, Brieva L, Mostert J, Strijbis EM, Comtois J, Repovic P, Bowen JD, Wolinsky JS, Lublin FD, Cutter G.
Mult Scler. 2023 Dec;29(14):1776-1785. doi: 10.1177/13524585231202320. Epub 2023 Oct 13.
Relapse risk factors in anti-N-methyl-D-aspartate receptor encephalitis.
Nosadini M, Granata T, Matricardi S, Freri E, Ragona F, Papetti L, Suppiej A, Valeriani M, Sartori S; Italian Working Group on Paediatric Anti-N-methyl-D-aspartate Receptor Encephalitis.
Dev Med Child Neurol. 2019 Sep;61(9):1101-1107. doi: 10.1111/dmcn.14267. Epub 2019 Jun 7.
